OTC and ornithine carbamoyltransferase deficiency: In 1999, in a clinical trial for ornithine transcarbamylase (OTC) deficiency, an Ad5 vector carrying the OTC gene was delivered to an 18-year-old male subject named Jesse Gelsinger.